Zeo ScientifiX (ZEOX) Cash from Investing Activities (2015 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Cash from Investing Activities of $312000.0 for Q2 2026, up 2328.57% quarter-over-quarter from -$14000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Zeo ScientifiX's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $312000.0 for Q2 2026.
- In Q2 2026, Cash from Investing Activities changed N/A year-over-year to $312000.0; the TTM figure through Apr 2026 stood at $298000.0 (changed N/A YoY), while the FY2025 annual figure was -$23000.0, up 48.89% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at $312000.0, up from -$14000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $735000.0 in Q4 2023, with the low at -$308224.0 in Q4 2022.
- The 3-year median for Cash from Investing Activities is -$58000.0 (2023), against an average of $8825.7.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities sank 235.32% in 2022, then jumped 338.46% in 2023.
- Zeo ScientifiX's Cash from Investing Activities stood at -$308224.0 in 2022, then jumped by 338.46% to $735000.0 in 2023, then plunged by 57.55% to $312000.0 in 2026.
- Business Quant data shows ZEOX's Cash from Investing Activities at $312000.0 in Q2 2026, -$14000.0 in Q1 2026, and $735000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 312,000.00 |
| Apr 30, 2026 | 312,000.00 |
| Jan 31, 2026 | -14,000.00 |
| Jan 31, 2026 | -14,000.00 |
| Oct 31, 2023 | 735,000.00 |
| Oct 31, 2023 | 735,000.00 |
| Jul 31, 2023 | -4,000.00 |
| Jul 31, 2023 | -4,000.00 |
| Apr 30, 2023 | -100,000.00 |
| Apr 30, 2023 | -100,000.00 |
| Jan 31, 2023 | -16,000.00 |
| Jan 31, 2023 | -16,000.00 |
| Oct 31, 2022 | -308,224.00 |
| Oct 31, 2022 | -308,224.00 |
| Jul 31, 2022 | -131,483.00 |
| Jul 31, 2022 | -131,483.00 |
| Apr 30, 2022 | -229,902.00 |
| Apr 30, 2022 | -229,902.00 |
| Jan 31, 2022 | -155,134.00 |
| Jan 31, 2022 | -155,134.00 |